CA19-9 as a serum marker for poor prognosis in urothelial carcinoma.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018395:CA-19-9 Antigen / Q000097:blood*; D002294:Carcinoma, Squamous Cell / Q000097:blood* / Q000473:pathology / Q000556:secondary; D002295:Carcinoma, Transitional Cell / Q000097:blood* / Q000473:pathology / Q000556:secondary; D005260:Female; D006801:Humans; D016015:Logistic Models; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000097:blood; D011379:Prognosis; D016019:Survival Analysis; D014571:Urologic Neoplasms / Q000097:blood* / Q000473:pathology; D019459:Urothelium / Q000378:metabolism / Q000473:pathology
D018395:CA-19-9 Antigen